NCT05385562View on ClinicalTrials.gov

Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 2, 2020

Primary Completion Date

May 1, 2022

Study Completion Date

May 10, 2022

Conditions
Macula Edema
Interventions
DRUG

Triamcinolone Acetonide and sodium hyaluronate and chondroitin sulfate

formulated with sodium hyaluronate and chondroitin sulfate

DRUG

Triamcinolone Acetonide alone

Triamcinolone Acetonide alone

Trial Locations (1)

34517

Ehab tharwat, Damietta

All Listed Sponsors
lead

Al-Azhar University

OTHER

NCT05385562 - Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions | Biotech Hunter | Biotech Hunter